Gainers

• Lunai Bioworks (NASDAQ:LNAI) stock moved upwards by 47.2% to $0.41 during Tuesday's regular session. The market value of their outstanding shares is at $6.8 million.
• SILO Pharma (NASDAQ:SILO) shares rose 46.0% to $0.52. The market value of their outstanding shares is at $4.7 million.
• Advanced Biomed (NASDAQ:ADVB) stock increased by 43.09% to $6.33. The market value of their outstanding shares is at $6.0 million.
• Estrella Immunopharma (NASDAQ:ESLA) stock increased by 35.25% to $1.84. The market value of their outstanding shares is at $58.0 million.
• Quince Therapeutics (NASDAQ:QNCX) shares rose 29.48% to $0.11. The company's market cap stands at $4.8 million.
• Axe Compute (NASDAQ:AGPU) shares increased by 26.58% to $5.38. The market value of their outstanding shares is at $14.4 million.

Losers

• Profusa (NASDAQ:PFSA) stock fell 33.0% to $1.24 during Tuesday's regular session. The market value of their outstanding shares is at $2.5 million.
• Grace Therapeutics (NASDAQ:GRCE) shares declined by 17.94% to $3.34. The market value of their outstanding shares is at $62.9 million.
• Aditxt (NASDAQ:ADTX) stock decreased by 16.13% to $0.5.
• Pulse Biosciences (NASDAQ:PLSE) shares declined by 15.2% to $19.45. The market value of their outstanding shares is at $1.5 billion.
• Cyclerion Therapeutics (NASDAQ:CYCN) shares fell 15.19% to $3.52. The market value of their outstanding shares is at $15.7 million.
• Neuronetics (NASDAQ:STIM) stock decreased by 14.49% to $1.5. The market value of their outstanding shares is at $121.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.